Susan is qualified in England and Wales as well as California, and has experience practicing law in both the United States and the United Kingdom. She has been based in Mintz Levin’s London office since September 2007, and worked in the United Kingdom for another international law firm from 2001 to 2004.
Susan works with clients primarily on licensing, collaborations, and commercial matters in the fields of clean tech, high tech, mobile media, and life sciences. She has represented a broad range of clients, from start-up companies to international industry leaders, and has significant experience with cross-border transactions.
Within the life sciences, Susan has assisted biotech, pharmaceutical, diagnostic, and medical device companies with licenses, collaborations, spin-offs, and agreements relating to consulting services, R&D, manufacturing, and distribution. She has also advised clients on intellectual property due diligence for transactions valued up to $27 billion.
Within the high-tech and mobile media fields, Susan has advised clients on deals involving the sale and licensing of intellectual property rights; multi-tier distribution arrangements; OEM and value-added reseller arrangements; research, development, and consulting activities; and the provision and outsourcing of technology services. She has assisted mobile media and Internet services clients with service agreements and content licenses, including user-generated content and web-to-mobile deals.
Susan’s clean tech experience includes advising on a joint venture for the development and marketing of electric cars and various agreements relating to the development and sale of fuel cells.
She has spoken on open source software, European antitrust and technology transfer law, and other intellectual property and technology law issues at a number of conferences in the United States and the United Kingdom.
During law school, Susan was on the executive board for the Stanford Technology Law Review.
Recognitions & Awards
Susan is qualified in England and Wales as well as California, and has experience practicing law in both the United States and the United Kingdom. She has been based in Mintz Levin’s London office since September 2007, and worked in the United Kingdom for another international law firm from 2001 to 2004.
Susan works with clients primarily on licensing, collaborations, and commercial matters in the fields of clean tech, high tech, mobile media, and life sciences. She has represented a broad range of clients, from start-up companies to international industry leaders, and has significant experience with cross-border transactions.
Within the life sciences, Susan has assisted biotech, pharmaceutical, diagnostic, and medical device companies with licenses, collaborations, spin-offs, and agreements relating to consulting services, R&D, manufacturing, and distribution. She has also advised clients on intellectual property due diligence for transactions valued up to $27 billion.
Within the high-tech and mobile media fields, Susan has advised clients on deals involving the sale and licensing of intellectual property rights; multi-tier distribution arrangements; OEM and value-added reseller arrangements; research, development, and consulting activities; and the provision and outsourcing of technology services. She has assisted mobile media and Internet services clients with service agreements and content licenses, including user-generated content and web-to-mobile deals.
Susan’s clean tech experience includes advising on a joint venture for the development and marketing of electric cars and various agreements relating to the development and sale of fuel cells.
She has spoken on open source software, European antitrust and technology transfer law, and other intellectual property and technology law issues at a number of conferences in the United States and the United Kingdom.
During law school, Susan was on the executive board for the Stanford Technology Law Review.
Recognitions & Awards
Speaking Engagements
-
Panelist,
Case Study: Oxford BioTherapeutics – Menarini deal,
Genesis 2012,
London, UK
-
Panelist,
Foreign Corrupt Practices Act (FCPA) & UK Bribery Act: Lessons to Be Learned from Current Developments,
Foreign Corrupt Practices Act (FCPA) and UK Bribery Act: Lessons to be Learned from Current Developm,
Mintz Levin, Webinar
-
Speaker,
NEIBC Biomed Israel Reception,
New England & Israel Life Sciences Connection
-
Speaker,
U.S. Legislative Update,
BIA Annual Bioscience Forum
-
Speaker,
Introduction,
Enterprise Tuesday ,
University of Cambridge Centre for Entrepreneurial Learning
Newsroom